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The Wilms’ tumor suppressor gene (WT1) is a transcrip-
tion factor that plays a major role in development of the
gonads and kidneys. It is expressed even earlier than sex-
determining region of the Y chromosome in the urogenital
ridge from which the gonads and kidneys are derived.
WT1 mutations will impair gonadal and urinary tract
development and have been demonstrated to cause syn-
dromes of WAGR, Denys–Drash and Fraiser. In this
study, our aim is to identify mutation in WT1 gene and to
describe clinical features of a Vietnamese patient with 46,
XY disorder of sex development (DSD) associated with
Wilms’ tumor. DNA was extracted from WBC and muta-
tion analysis of WT1 gene was performed using PCR and
direct sequencing. A 5 days newborn presented with peno-
scrotal hypospadias, microphallus, right testis in the right
inguinal and no left testis was found. Karyotype was 46,XY
and no ovaries and uterus were found using pelvic ultra-
sound. Wilms’ tumor was detected at 13 months of age by
abdominal ultrasound and CT scan. Mutation analysis was
identified a heterozygous missense mutation (c.1390G>A;
p.D464N) in exon 9 of WT1 gene. In conclusions, WT1
analysis should be performed in newborns with complex
hypospadias with at least one cryptorchid testis and in iso-
lated 46,XY partial to complete gonadal dysgenesis. WT1
analysis is mandatory in all 46,XY DSD with associated
kidney disease. Patients with WT1 mutations should be
followed up closely because the risk of developing a
Wilms’ tumor, nephropathy.
Written informed consent was obtained from the
patient’s parent or guardian for publication of this Case
report (and any accompanying images). A copy of the
written consent is available for review by the Editor-in-
Chief of this journal.
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